Zeng Liping, Liu Xiufang, Yang Tao, Zhao Baomin, Tuo Houshuai
Previous studies have shown that the commonly used statin lipid lowering drugs can delay the progression of atherosclerotic plaque
Rosuvastatin
lipid-lowering drug
safety index
reverse plaque
adverse drug reaction